Upcoming Events
  1. ALTG closed SAC and MAC meetings

    May 1 @ 8:00 am - 5:00 pm
  2. 6th ALTG Lung Cancer Preceptorship

    October 23 @ 10:00 am - October 24 @ 3:30 pm
  3. ALTG open MAC and SAC meetings

    November 20

President’s Message

Welcome back after a bit of a break from the newsletter thanks to a busy twelve months, with several key events alongside the usual schedule of Australian and international scientific meetings, including completion of accrual to NITRO, the  initiation of BR31, our first Preceptorship and two idea generation workshops. The next 6 to 12 months promises to be equally busy and we are keen to hear from other members who would like to be involved.

A key focus of ALTG over the last year has been to build up our trial portfolio.  The idea generation workshops were particularly helpful for this and there are plans to continue this activity. There are several trials currently under discussion with industry sponsors and we would expect at least one or two of these to go forward. Likewise the Preceptorship was a great way to engage with trainees and the ALTG is working with the Lung Foundation to plan a second event in 2016.

ALTG now has an early lung cancer interest group, bringing together clinicians, scientists and researchers focused on diagnosing and treating lung cancer when it is most curable. Low-radiation dose CT lung scan screening in smokers at high risk of cancer has already been implemented in some countries and we need to work on how this can most effectively employed in Australia.

Karen has moved on to another job with the Lung Foundation, after many years supporting ALTG. Without effective central administrative support, co-operative trials groups such as ALTG couldn’t exist. Karen – A VERY BIG THANK YOU FOR ALL YOUR DEDICATION AND HARD WORK.

And hello to Ros, whose appointment is the result of the ALTG’s development to this point – Ros will be helping to maintain and drive the group’s current portfolio of activities as well as actively seeking opportunities for continued growth and development.

The international lung cancer trials group initiative (Thoracic Alliance for Cancer Trials, TACT) is an excellent example of the ALTG’s success to date – spearheading the steering committee to establish this exciting global initiative is a great demonstration of the group’s enthusiasm and efforts.